RXRA and urinary bladder cancer: This network module contains the known bladder cancer driver TSC1 (and 9 other-known cancer drivers) and 5 putative bladder cancer drivers one of which is RXRA, whose mutation activates the peroxisome proliferator-activated receptors, which switch on genes driving cell proliferation [32].